Journal of
Terminal Oncology^™

Robert L. Barkin, MBA, PharmD, FAC, Rush-Presbyterian-St. Luke’s Medical Center; Consultant, Rush Pain Center and Rush North Shore Pain Center; Departments of Anesthesiology, Orthopedic Surgery, Psychiatry, Pharmacology, Family Medicine, and Nursing, Rush Medical College, Chicago, Illinois.

Patrick Bergevin, MD, Medical Director, Oncologist, Lourdes Hospice, Binghamton, New York.

William Breitbart, MD, Professor of Clinical Psychiatry, Weill Medical College, Cornell University; Chief, Psychiatry Service, Department of Psychiatry and Behavioral Sciences, and Attending Psychiatrist, Pain and Palliative Care Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York.

Frank J. Brescia, MD, Professor of Medicine and Medical Director, Palliative and Supportive Care, Medical University of South Carolina; Division of Hematology and Oncology, Hollings Cancer Center, Charleston, South Carolina; Adjunct Professor, Department of Philosophy, Georgetown University, Washington, DC; Fellow, Joseph and Rose Kennedy Institute of Ethics, Georgetown University, Washington, DC.

Michael A. Carducci, MD, Associate Professor of Oncology and Urology, Division of Medical Oncology and Experimental Therapeutics; Co-Director, Drug Development Program; Co-Chair, Palliative Care Task Force, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore Maryland.

Mellar P. Davis, MD, FCCP, Medical Director, The Harry R. Horvitz Center for Palliative Medicine, Taussig Cancer Center of the Cleveland Clinic, Cleveland, Ohio.

E. Duke Dickerson, MSc, PhD, Fellow, Oxford International Centre for Palliative Care; Academic Associate, Sobell Study Centre, Oxford, UK; Health Sciences and Systems, Columbus, Ohio.

Gilbert J. Fanciullo, MD, MS, Director, Pain Medicine and Palliative Care, and Associate Professor of Anesthesiology, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, Lebanon, New Hampshire.

Walter B. Forman, MD, FACP, CMD,Medical Director, Delta Hospice; Professor, Palliative Care Project, Cancer Research and Treatment Center, University of New Mexico School of Medicine, Albuquerque, New Mexico.

Jan Halle, MD, Clinical Assistant Professor, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

J. Cameron Muir, MD, Assistant Professor, Department of Hematology/Oncology, Feinberg School of Medicine, Northwestern University; Medical Director, Palliative Care Program, Northwestern Memorial Hospital, Chicago, Illinois.

Samuel Lee Oliver, MDiv, BCC, Pastoral Counselor, Hospice of St. Joseph County, South Bend, Indiana.

Marco Pappagallo, MD, Director, Comprehensive Pain & Palliative Care, New York University School of Medicine, New York, New York.

Steven D. Passik, PhD, Director of Symptom Management and Palliative Care, and Associate Professor of Medicine and Behavioral Sciences, Markey Cancer Center, University of Kentucky, Lexington, Kentucky.

William Rock, MD, Corporate Medical Director, Emeritus, Dean Health Systems; Medical Director/Professional Education, HospiceCare, Inc., Madison, Wisconsin.

Paul Rousseau, MD, Associate Chief-of-Staff for Geriatrics and Extended Care, Veterans Affairs Medical Center, Phoenix, Arizona.

Joel Schor, MD, Bluefield Hematology/Oncology Associates, Bluefield, West Virginia.

Joanne E. Sheldon, RN, MEd, CRNH, CIC, Education Coordinator, the Hospice Institute, Hospice of the Western Reserve, Cleveland, Ohio.

Matt Stolick, PhD, Assistant Professor of Philosophy, University of Findlay, Findlay Ohio.

Joseph S. Weiner, MD, PhD, Director, Program in the Patient-Doctor Relationship; Training Director, Primary Care Psychiatry, Long Island Jewish Medical Center, New Hyde Park, New York.